KMID : 1225720230150010032
|
|
Allergy, Asthma & Immunology Research : AAIR 2023 Volume.15 No. 1 p.32 ~ p.42
|
|
Chronic Spontaneous Urticaria in Hong Kong: Clinical Characteristics, Real-World Practice and Implications for COVID-19 Vaccination
|
|
Kan Andy Ka Chun
Wong Thomas Tsz Hang Chiang Valerie Lau Chak Sing Li Philip Hei
|
|
Abstract
|
|
|
Purpose : The real-world management and clinical characteristics of chronic spontaneous urticaria (CSU) in Hong Kong and its implications for coronavirus disease 2019 (COVID-19) vaccination are unknown. We investigated the clinical characteristics of patients with CSU and the role of an immunologist-led Urticaria Clinic as well as the impact of CSU on COVID-19 vaccine uptake in Hong Kong.
Methods : Longitudinal clinical data of 257 CSU patients were collected and analyzed. Association analyses were performed to identify the relationships between variables and factors associated with COVID-19 vaccine uptake.
Results : After the immunologist review, the Weekly Urticaria Activity Score (UAS7) was significantly lower than baseline (median: 0.00 vs. 12.0, P < 0.001). Changes in UAS7 were significantly greater among patients with baseline UAS7 ¡Ã 16 compared to those with UAS7 < 16 (median: ?24.0 vs. ?2.00, P < 0.001). CSU patients had lower COVID-19 vaccination rates than the general population with only 176 (68.5%) and 165 (65.0%) receiving at least one dose and 2 doses of vaccination, respectively. The presence of concomitant suspected drug allergy was associated with lower COVID-19 vaccine uptake (odds ratio [OR], 0.47; P = 0.010), while regular pharmacological treatment was associated with higher COVID-19 vaccine uptake among CSU patients (OR, 3.79; P = 0.010).
Conclusions : A dedicated immunologist-led Urticaria Clinic may effectively improve CSU management and outcomes in Hong Kong.
|
|
KEYWORD
|
|
Chronic spontaneous urticaria, Hong Kong, COVID-19, vaccines, drug hypersensitivity
|
|
FullTexts / Linksout information
|
|
|
|
Listed journal information
|
|
|